United Therapeutics (UTHR) Pursues New Claims For Trade Secret Misappropriation Against Liquidia (LQDA)

Go back to United Therapeutics (UTHR) Pursues New Claims For Trade Secret Misappropriation Against Liquidia (LQDA)

United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

June 7, 2021 6:00 AM EDT

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 7, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it is pursuing additional claims for trade secret misappropriation against Liquidia Technologies, Inc. (a subsidiary of Liquidia Corporation, Nasdaq: LQDA) and a former United Therapeutics employee who later joined Liquidia as an executive. The claims allege that Liquidia conspired with the former employee to misappropriate United Therapeutics' trade secrets, including regulatory submissions and detailed financial forecasts, in the development of Liquidia's product, LIQ861.

United... More